国新健康：关于全资子公司与中国国新关联交易的公告

Core Points - Guoxin Health announced the approval of a related party transaction with China Guoxin, involving the construction of a legal compliance intelligent review system for equity investment [2] - The contract amount for the project is RMB 2,840,000, which includes tax [2] - The transaction is classified as a related party transaction since China Guoxin is the actual controller of the company [2]